ABOUT US

Corporate information

[Company name]

Mirai Lab Bioscience Co., Ltd.

[Establishment]

October 2016

[Capital]

20 million yen

【main office】

1-14-4 Ginza, Chuo-ku, Tokyo

[Kanagawa branch office]

2-13-22 Higashikaiganminami, Chigasaki City, Kanagawa Prefecture

[Kobe branch office]

1-5-2 Minatojima Minamimachi, Chuo-ku, Kobe City, Hyogo Prefecture  Kobe Kimec Center Building 7th floor

[Research Institute]

Ginza Research Institute (Life Science Lab)
1-14-4 Ginza, Chuo-ku, Tokyo Prairie Ginza Building 6th floor

【CEO】

Megumi Tanaka

[Medical adviser]

Yoichi Nabeshima Specially Appointed Professor, Department of Health and Aging Medicine, Graduate School of Medicine, Kyoto University

[Science Advisor]

Takashi Hiramatsu (Public Foundation) Kobe Medical Industry City Promotion Organization  Executive Coordinator

[Adviser]

Osamu Kimura Former Public Security Intelligence Agency  Chief Investigator

[Research Partner]

Hiroaki Kitano Chairman , System Biology Research Organization, NPO

[Medical support]

Medical Incorporated Association Mirai Kai

Tokyo Ginza Wellness & Aging Clinic

【Member】

Japan Productive Aging Alliance (JAPA)

Japan Anti-Aging Dental Association (JSDA)

Informed Certification Consortium (ICC)

General Incorporated Association Pet Disease Study Group

Okinawa Institute of Science and Technology (OIST)

Business content

・ Biotechnology research

・ Research, development, manufacturing and sales of nutraceuticals (health foods and cosmetics)

・ Research, development, manufacturing and sales of pharmaceuticals and quasi-drugs

・ Manufacture and sale of medical equipment, medical consumables and sanitary materials

・ Research, research and consulting on medicine, medicine and pharmaceuticals

・ Comprehensive support services and consulting for medical institutions (medical support services)

・ Management consulting business

・ Import / export business and sales of domestic and foreign goods

 

Major business partners Various research institutes, domestic and overseas sales destination companies, platforms, etc.

Affiliated companies MIRAILAB BIOSCIENCE USA INC., Hakumado Pharmaceutical Co., Ltd., Orient International Co. , Ltd.

Partner Medical Institution TAM (former Sannomiya Orthopedic Clinic), Otani Orthopedic Hospital, Medical Corporation Meihokai Nihonbashi Midori Ophthalmology Clinic

Medical Corporation Kenseikai Kendental Clinic Komaki Clinic, Medical Corporation Kenseikai LDC International Dental Clinic

Azusawa Orthopedic Surgery

​History

April 2015

Started selling Nutracutical containing NMN from Shinkowa Trading Co., Ltd.

 

December 2015

Company name changed from Shinwa Trading Co., Ltd. to Shinkowa Pharmaceutical Co., Ltd.

 

April 2019

Orient Biomedic Co., Ltd. took over NMN research and all business from Shinkowa Pharmaceutical Co., Ltd. and changed the company name to Shinkowa Pharmaceutical Co., Ltd.

 

July 2019

Opened our own NMN research facility "Life Science Lab" at 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo (Nihonbashi Life Science Building B1F)

 

September 2020

Opened Kobe branch office on the 7th floor of Kobe Kimec Center Building, 1-5-2 Minatojima Minamimachi, Chuo-ku, Kobe City, Hyogo Prefecture, in collaboration with the General Incorporated Association Productive Aging Research Organization (IRPA).

 

January 2021

Company name changed from Shinwa Pharmaceutical Co., Ltd. to Mirai Lab Bioscience Co., Ltd.

July 2021

Moved in-house NMN research facility "Life Science Lab" to the 6th floor of Prairie Ginza Building, 1-14-4 Ginza, Chuo-ku, Tokyo

February 2022

Headquarters moved to the 5th floor of Prairie Ginza Building, 1-14-4 Ginza, Chuo-ku, Tokyo

 
grass.jpeg

NOW MAKE NEXT

The MIRAILAB BIOSCIENCE mission is to improve the well-being of our customers and society through rigorous development of productive aging science.

 

In about 40 years, the world population will exceed 10 billion, while the elderly in developed regions will reach 27.6% of the population amid declining birth rates.

 

The arrival of a “super-aging” society is becoming an issue not only in Japan but worldwide.

 

And Japan, with its aging population already exceeding 28%, is now faced with a new challenge: how to extend healthy life expectancy while absolute life expectancy is increasing due to advances in medical technology.

 

In light of this, MIRAILAB BIOSCIENCE is developing NMN-based nutraceuticals, inspired by the potential discovered in the early research of pioneering scientists and motivated by positive results in clinical trials and the feedback of our customers.

 

How far can science expand the possibilities of humankind?

How well can we reflect the benefits of science in our lives?

MIRAILAB BIOSCIENCE Inc. aspires to a new level of Quality Of Life.